Discontinued — last reported Q1 '24
Other
2031
Abbott 2031 decreased by 40.0% to $363.00M in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), 2031 shows a downward trend with a -32.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2024
How to read this metric
Lower projected expenses in later years indicate the eventual expiration of amortization schedules for older acquisitions.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2031. It is part of t...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_5777a7Historical Data
4 periods
| Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|
| Value | $1.20B | $700.00M | $605.00M | $363.00M |
| QoQ Change | — | -41.7% | -13.6% | -40.0% |
| YoY Change | — | -41.7% | -13.6% | -40.0% |
Range$363.00M – $1.20B
Avg YoY Growth-31.7%
Median YoY Growth-40.0%
Current Streak3+ quarters decline
2031 at Other Companies
Frequently Asked Questions
- What is Abbott's 2031?
- Abbott (ABT) reported 2031 of $363.00M in Q4 2025.
- What is the long-term trend for Abbott's 2031?
- Over 3 years (2022 to 2025), Abbott's 2031 has grown at a -32.9% compound annual growth rate (CAGR), from $1.20B to $363.00M.
- What does 2031 mean?
- The expected non-cash expense for acquired intangible assets in the year 2031.